Pfizer previously told The Associated Press that early data from the company’s booster study suggests people’s antibody levels jump five-to-10-fold after a third dose. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.